{"id":"https://openalex.org/W4414201211","doi":"https://doi.org/10.7759/cureus.92375","title":"Chlorpheniramine Maleate Displaying Multiple Modes of Antiviral Action Against SARS-CoV-2: An Initial Mechanistic Study","display_name":"Chlorpheniramine Maleate Displaying Multiple Modes of Antiviral Action Against SARS-CoV-2: An Initial Mechanistic Study","publication_year":2025,"publication_date":"2025-09-15","ids":{"openalex":"https://openalex.org/W4414201211","doi":"https://doi.org/10.7759/cureus.92375","pmid":"https://pubmed.ncbi.nlm.nih.gov/40988968","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12453291"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.92375","doi":"https://doi.org/10.7759/cureus.92375","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.92375","pdf_url":"https://www.cureus.com/articles/399658-chlorpheniramine-maleate-displaying-multiple-modes-of-antiviral-action-against-sars-cov-2-an-initial-mechanistic-study.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/399658-chlorpheniramine-maleate-displaying-multiple-modes-of-antiviral-action-against-sars-cov-2-an-initial-mechanistic-study.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020831807","display_name":"Yaseen A. M. M. Elshaier","orcid":"https://orcid.org/0000-0003-4332-6345","observed_orcids":["https://orcid.org/0000-0003-4332-6345"]},"institutions":[{"id":"https://openalex.org/I338016083","display_name":"University of Sadat City","ror":"https://ror.org/05p2q6194","country_code":"EG","type":"education","lineage":["https://openalex.org/I338016083"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Yaseen A Elshaier","raw_affiliation_strings":["Organic and Medical Chemistry Department, University of Sadat City, Sadat City, EGY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organic and Medical Chemistry Department, University of Sadat City, Sadat City, EGY","institution_ids":["https://openalex.org/I338016083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107910392","display_name":"Ahmed Mostafa","orcid":"https://orcid.org/0000-0002-2878-5714","observed_orcids":["https://orcid.org/0000-0002-2878-5714"]},"institutions":[{"id":"https://openalex.org/I4210131959","display_name":"National Research Centre","ror":"https://ror.org/02n85j827","country_code":"EG","type":"facility","lineage":["https://openalex.org/I4210131959"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Ahmed Mostafa","raw_affiliation_strings":["Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, EGY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, EGY","institution_ids":["https://openalex.org/I4210131959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079810532","display_name":"Joshua M. Costin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203088144","display_name":"Nova Southeastern University","ror":"https://ror.org/042bbge36","country_code":"US","type":"education","lineage":["https://openalex.org/I203088144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Costin","raw_affiliation_strings":["Medical Education Department, Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine, Fort Lauderdale, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Education Department, Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine, Fort Lauderdale, USA","institution_ids":["https://openalex.org/I203088144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102907301","display_name":"Syed A. A. Rizvi","orcid":"https://orcid.org/0000-0002-0162-5294","observed_orcids":["https://orcid.org/0000-0002-0162-5294"]},"institutions":[{"id":"https://openalex.org/I4210097871","display_name":"Larkin University","ror":"https://ror.org/00zjk7642","country_code":"US","type":"education","lineage":["https://openalex.org/I4210097871"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Syed A A Rizvi","raw_affiliation_strings":["Biomedical Sciences Department, Larkin University, Miami, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Sciences Department, Larkin University, Miami, USA","institution_ids":["https://openalex.org/I4210097871"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055914263","display_name":"Dennis Javier Pav\u00f3n-Varela","orcid":"https://orcid.org/0000-0003-4796-5902","observed_orcids":["https://orcid.org/0000-0003-4796-5902"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dennis J Pav\u00f3n-Varela","raw_affiliation_strings":["Research and Development Department, Dr. Ferrer Biopharma, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Department, Dr. Ferrer Biopharma, Florida, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027601962","display_name":"Kristhel Gait\u00e1n\u2010Zambrano","orcid":"https://orcid.org/0000-0001-9124-194X","observed_orcids":["https://orcid.org/0000-0001-9124-194X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristhel Gait\u00e1n-Zambrano","raw_affiliation_strings":["Research and Development Department, Dr. Ferrer Biopharma, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Department, Dr. Ferrer Biopharma, Florida, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014489910","display_name":"C\u00e9sar Alas\u2010Pineda","orcid":"https://orcid.org/0000-0003-4183-9104","observed_orcids":["https://orcid.org/0000-0003-4183-9104"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"C\u00e9sar Alas-Pineda","raw_affiliation_strings":["Research and Development Department, Dr. Ferrer Biopharma, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Department, Dr. Ferrer Biopharma, Florida, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5014489910"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1895,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.72764776,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"17","issue":"9","first_page":"e92375","last_page":"e92375"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chlorpheniramine-maleate","display_name":"chlorpheniramine maleate","score":1.0},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.9649999737739563},{"id":"https://openalex.org/keywords/virus-attachment","display_name":"viral attachment","score":0.734000027179718},{"id":"https://openalex.org/keywords/viral-replication","display_name":"viral replication","score":0.800000011920929},{"id":"https://openalex.org/keywords/virucidal-activity","display_name":"virucidal activity","score":0.9800000190734863},{"id":"https://openalex.org/keywords/angiotensin-converting-enzyme-2-receptor","display_name":"angiotensin-converting enzyme 2 receptor","score":0.9210000038146973},{"id":"https://openalex.org/keywords/main-protease","display_name":"main protease","score":0.8930000066757202},{"id":"https://openalex.org/keywords/spike-protein","display_name":"spike protein","score":0.9300000071525574},{"id":"https://openalex.org/keywords/rna-polymerase","display_name":"RNA polymerase","score":0.996999979019165},{"id":"https://openalex.org/keywords/hydrophobic-interactions","display_name":"hydrophobic interactions","score":0.765999972820282},{"id":"https://openalex.org/keywords/hydrogen-bonding","display_name":"hydrogen bonding","score":0.546999990940094},{"id":"https://openalex.org/keywords/vero-e6-cells","display_name":"Vero E6 cells","score":0.8149999976158142}],"concepts":[{"id":"https://openalex.org/C89138240","wikidata":"https://www.wikidata.org/wiki/Q3066564","display_name":"Vero cell","level":3,"score":0.7095999717712402},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.5727999806404114},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.544700026512146},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.532800018787384},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4916999936103821},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.46939998865127563},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4677000045776367},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.41769999265670776},{"id":"https://openalex.org/C2777648638","wikidata":"https://www.wikidata.org/wiki/Q57751738","display_name":"Coronavirus","level":5,"score":0.384799987077713},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.36910000443458557},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.36090001463890076},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3564000129699707},{"id":"https://openalex.org/C2776449523","wikidata":"https://www.wikidata.org/wiki/Q272631","display_name":"RNA polymerase","level":4,"score":0.35339999198913574},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33880001306533813},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.335099995136261},{"id":"https://openalex.org/C121587506","wikidata":"https://www.wikidata.org/wiki/Q6888113","display_name":"Mode of action","level":2,"score":0.33309999108314514},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.32670000195503235},{"id":"https://openalex.org/C2779756493","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral drug","level":3,"score":0.323199987411499},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.3037000000476837},{"id":"https://openalex.org/C58475186","wikidata":"https://www.wikidata.org/wiki/Q4118894","display_name":"Viral entry","level":4,"score":0.2971000075340271},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.28209999203681946},{"id":"https://openalex.org/C90260826","wikidata":"https://www.wikidata.org/wiki/Q899157","display_name":"Hydrophobic effect","level":2,"score":0.2671999931335449},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2547999918460846}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.7759/cureus.92375","doi":"https://doi.org/10.7759/cureus.92375","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.92375","pdf_url":"https://www.cureus.com/articles/399658-chlorpheniramine-maleate-displaying-multiple-modes-of-antiviral-action-against-sars-cov-2-an-initial-mechanistic-study.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:11262473","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12453291","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:40988968","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40988968","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12453291","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12453291/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.7759/cureus.92375","doi":"https://doi.org/10.7759/cureus.92375","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.92375","pdf_url":"https://www.cureus.com/articles/399658-chlorpheniramine-maleate-displaying-multiple-modes-of-antiviral-action-against-sars-cov-2-an-initial-mechanistic-study.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4414201211.pdf","grobid_xml":"https://content.openalex.org/works/W4414201211.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W177656516","https://openalex.org/W2036927671","https://openalex.org/W2037650802","https://openalex.org/W2045458882","https://openalex.org/W2899959274","https://openalex.org/W3007643904","https://openalex.org/W3015608194","https://openalex.org/W3030266358","https://openalex.org/W3038301678","https://openalex.org/W3040498098","https://openalex.org/W3048560736","https://openalex.org/W3087243618","https://openalex.org/W3109172892","https://openalex.org/W3109598707","https://openalex.org/W3122698449","https://openalex.org/W3149049984","https://openalex.org/W3200879896","https://openalex.org/W4205386205","https://openalex.org/W4225877482","https://openalex.org/W4281675175","https://openalex.org/W4306734762"],"related_works":["https://openalex.org/W4386293798","https://openalex.org/W3087243618","https://openalex.org/W4205386205","https://openalex.org/W3200879896","https://openalex.org/W3195944125","https://openalex.org/W4206460363","https://openalex.org/W3083134270","https://openalex.org/W4280497421","https://openalex.org/W3128706316","https://openalex.org/W3037100911"],"abstract_inverted_index":{"Background":[0],"Chlorpheniramine":[1],"maleate":[2],"(CPM)":[3],"has":[4,138],"been":[5],"identified":[6],"as":[7,83,85,102,143],"a":[8,144],"potential":[9,140],"antiviral":[10,24,40,74,146],"compound":[11],"against":[12,28,148],"severe":[13],"acute":[14],"respiratory":[15,153],"syndrome":[16],"coronavirus":[17],"2":[18,65],"(SARS-CoV-2).":[19],"Materials":[20],"and":[21,39,48,61,81,97,110,150,164],"methods":[22],"The":[23],"activity":[25],"of":[26],"CPM":[27,72,96,137],"SARS-CoV-2":[29,149],"was":[30,53],"evaluated":[31],"in":[32,118,126,168],"vitro":[33],"using":[34],"Vero":[35],"E6":[36],"cells.":[37],"Cytotoxicity":[38],"assays":[41],"assessed":[42],"effects":[43],"on":[44],"viral":[45,59,79,99],"adsorption,":[46],"replication,":[47,82],"virucidal":[49],"activity.":[50],"Molecular":[51,90],"docking":[52,91],"conducted":[54],"to":[55,141,159],"explore":[56,160],"interactions":[57,94,114],"with":[58,78,120],"proteins":[60],"the":[62,88,103,127,139],"angiotensin-converting":[63],"enzyme":[64],"receptor.":[66],"Results":[67],"Our":[68],"findings":[69],"demonstrate":[70],"that":[71,136],"exhibits":[73],"properties":[75],"by":[76],"interfering":[77],"adsorption":[80],"well":[84],"directly":[86],"inactivating":[87],"virus.":[89],"analysis":[92],"revealed":[93],"between":[95],"essential":[98],"proteins,":[100],"such":[101],"main":[104],"protease":[105],"receptor,":[106,109],"spike":[107],"protein":[108],"RNA":[111,128],"polymerase.":[112],"CPM's":[113],"were":[115],"primarily":[116],"hydrophobic":[117],"nature,":[119],"an":[121],"additional":[122],"hydrogen":[123],"bond":[124],"formation":[125],"polymerase":[129],"active":[130],"site.":[131],"Conclusions":[132],"These":[133],"results":[134],"suggest":[135],"serve":[142],"multitarget":[145],"agent":[147],"potentially":[151],"other":[152],"viruses.":[154],"Further":[155],"investigations":[156],"are":[157],"warranted":[158],"its":[161,166],"clinical":[162],"implications":[163],"assess":[165],"efficacy":[167],"vivo.":[169]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-10-10T00:00:00"}